ArticleCancers2021

Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer.

Bernhard TribukaitPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.